Skip to main content
Veterinary Medicines

Canigen L4 (--) - Suspension for injection

Authorised
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated

Product identification

Medicine name:
Canigen L4 (--) - Suspension for injection
Active substance:
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated
    Presentation_strength:3550-7100 U Reference:Hse Index:0
  • Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain Ic-02-001, Inactivated
    Presentation_strength:290-1000 U Reference:Hse Index:1
  • Leptospira interrogans, serogroup Australis, serovar Bratislava, strain As-05-073, Inactivated
    Presentation_strength:500-1700 U Reference:Hse Index:2
  • Leptospira kirschneri, serogroup Grippotyphosa, serovar Dadas, strain GR-01-005, Inactivated
    Presentation_strength:650-1300 U Reference:Hse Index:3
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AB01
Authorisation status:
  • Valid
Authorised in:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Package description:
  • Packaging:Vial (glass), Package_size:50 vials, Content:1 ml (1 dose)
  • Packaging:Vial (glass), Package_size:10 vials, Content:1 ml (1 dose)
  • Packaging:Vial (glass), Package_size:1 vial, Content:10 ml (10 doses)

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • INTERVET INTERNATIONAL B.V.
Responsible authority:
  • European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

English (PDF)
Published on: 1/09/2023
Download
Bulgarian (PDF)
Published on: 1/09/2023
Croatian (PDF)
Published on: 1/09/2023
Czech (PDF)
Published on: 1/09/2023
Danish (PDF)
Published on: 1/09/2023
Dutch (PDF)
Published on: 1/09/2023
Estonian (PDF)
Published on: 1/09/2023
Finnish (PDF)
Published on: 1/09/2023
French (PDF)
Published on: 1/09/2023
German (PDF)
Published on: 1/09/2023
Greek (PDF)
Published on: 1/09/2023
Hungarian (PDF)
Published on: 1/09/2023
Icelandic (PDF)
Published on: 1/09/2023
Italian (PDF)
Published on: 1/09/2023
Latvian (PDF)
Published on: 1/09/2023
Lithuanian (PDF)
Published on: 1/09/2023
Maltese (PDF)
Published on: 1/09/2023
Norwegian (PDF)
Published on: 1/09/2023
Polish (PDF)
Published on: 1/09/2023
Portuguese (PDF)
Published on: 1/09/2023
Romanian (PDF)
Published on: 1/09/2023
Slovak (PDF)
Published on: 1/09/2023
Slovenian (PDF)
Published on: 1/09/2023
Spanish (PDF)
Published on: 1/09/2023
Swedish (PDF)
Published on: 1/09/2023

ema-puar-canigen-v-4079-par-en.pdf

English (PDF)
Published on: 13/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."